Research: Low-Dose Naltrexone Ineffective for Fibromyalgia
Research: Low-Dose Naltrexone Ineffective for Fibromyalgia Read More »
Low dose naltrexone proves disappointing for fibromyalgia patients in recent trial.
Research: Low-Dose Naltrexone Ineffective for Fibromyalgia Read More »
Low dose naltrexone proves disappointing for fibromyalgia patients in recent trial.
ME/CFS and Long Covid Research: 27 November – 04 December 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Last month Ellie Jones, Welfare Rights Adviser to the ME Association, met with the Director of Health at Ingeus.
The ME Association Annual General Meeting: Chairman’s Statement Read More »
2023 has been a year of change at the ME Association. Change within our staff and our Board of Trustees…
ME/CFS and Long Covid Research: 21 – 27 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Medscape: New Tests May Finally Diagnose Long Covid Read More »
One of the biggest challenges facing clinicians who treat long
Many people with Long Covid exhibit an array of symptoms known as autonomic dysfunction (dysautonomia) and include fatigue, post exertional malaise (PEM),
orthostatic intolerance (including postural orthostatic tachycardia
syndrome [POTS]), palpitations, dizziness, exercise intolerance, pain,
brain fog, gastrointestinal symptoms, and temperature dysregulation.
The ME Association Postural Orthostatic Tachycardia Syndrome Survey Results Read More »
The ME Association shares results from October’s Postural Orthostatic Tachycardia Syndrome (PoTS) survey.
The Times: ‘Hospitals have no services for most severe ME cases, coroner told’ Read More »
Maeve Boothby-O’Neill, the daughter of the Times journalist Sean O’Neill, died 2 years ago after becoming bedbound.
ME Association Research Review: Mortality in ME/CFS Read More »
Malnutrition is the most serious life-threatening complication in those with ME/CFS, especially in very severe cases.
BBC News: ‘Long Covid triggered our MCAS, but doctors didn’t believe us’. Read More »
“A growing number of people have secondary illnesses thought to be triggered by Long Covid – including an immune disorder called MCAS…”
ME/CFS and Long Covid Research: 16 – 20 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Dr Charles Shepherd responds to MP Jim Shannon about the similarities and overlap of ME/CFS and Long Covid
Living with M.E. A Photographic Study by Jeremy Jeffs Read More »
Photographer Jeremy Jeffs is looking for more people to take part in a project that aims to give identity and visibility to people who are living with M.E.
ME/CFS and Long Covid Research: 06 – 15 November 2023 Read More »
The weekly research round-up includes recent publications about ME/CFS and Long Covid.
Raman research set to continue thanks to Ramsay Research funding from the ME Association Read More »
The ME Association (MEA) is pleased to announce that the
TIME Magazine: A new radical approach needed for Long COVID research Read More »
With no treatment or cure in sight for Long Covid patients, who is really to blame for 3 years of disappointing clinical research results?
Rapamycin Pilot Treatment Trial for ME/CFS Read More »
Rapamycin therapy inhibits mTOR and reduces autophagy disruption. We believe
Research: Long Covid treatment trial: Donepezil hydrochloride Read More »
The effect of donepezil hydrochloride on post-COVID memory impairment: A